ALLT vs MSFT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Allot Ltd. (ALLT) exhibits a Piotroski F-Score of 4/9, indicating weak financial health and signaling potential distress despite strong growth metrics. The absence of an Altman Z-Score raises concern about bankruptcy risk, particularly given inconsistent earnings and a history of losses. While the company shows impressive revenue and earnings growth (14% YoY and 877% YoY EPS growth), these are driven by volatile, non-recurring gains and a recent sharp decline in Q/Q EPS growth. The stock trades at a high forward P/E of 15.54 and a current P/E of 80.62, suggesting overvaluation relative to its modest profitability and Graham Number of $2.05. Despite a strong analyst consensus of 'strong_buy', the technical trend is bearish and insider sentiment is neutral, underscoring caution.
Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.
Compare Another Pair
Related Comparisons
ALLT vs MSFT: Head-to-Head Comparison
This page compares Allot Ltd. (ALLT) and Microsoft Corporation (MSFT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.